Front Row Advisors LLC Crispr Therapeutics Ag Transaction History

Front Row Advisors LLC

$271 Million
Q3 2024

A detailed history of Front Row Advisors LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Front Row Advisors LLC holds 116 shares of CRSP stock, worth $4,604. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116

Previous 116 -0.0%

Holding current value

$4,604

Previous $6,000 16.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$38.62 - $72.18 $27,806 - $51,969	-720 Reduced 86.12%	116 $7,000
Q3 2023 Nov 15, 2023	SELL	$45.39 - $59.0 $718,614 - $934,088	-15,832 Reduced 94.98%	836 $37,000
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $26,082 - $40,662	-600 Reduced 3.47%	16,668 $936,000
Q1 2023 May 22, 2023	BUY	$41.0 - $56.12 $675,967 - $925,250	16,487 Added 2111.01%	17,268 $781,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $683,347 - $935,352	-16,667 Reduced 95.52%	781 $1.73 Million
Q4 2022 Feb 15, 2023	SELL	$39.19 - $65.67 $55,061 - $92,266	-1,405 Reduced 7.45%	17,448 $709,000
Q3 2022 Nov 15, 2022	SELL	$61.1 - $83.78 $17,535 - $24,044	-287 Reduced 1.5%	18,853 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $864 - $1,476	-20 Reduced 0.1%	19,140 $1.16 Million
Q1 2022 May 11, 2022	BUY	$53.19 - $79.24 $5,319 - $7,923	100 Added 0.52%	19,160 $1.2 Million
Q4 2021 Mar 09, 2022	BUY	$70.09 - $111.29 $90,696 - $144,009	1,294 Added 7.28%	19,060 $1.44 Million
Q3 2021 Nov 03, 2021	BUY	$110.2 - $156.64 $24,795 - $35,244	225 Added 1.28%	17,766 $1.99 Million
Q2 2021 Aug 23, 2021	BUY	$100.84 - $161.89 $105,176 - $168,851	1,043 Added 6.32%	17,541 $2.05 Million
Q1 2021 Apr 28, 2021	BUY	$110.72 - $210.04 $59,345 - $112,581	536 Added 3.36%	16,498 $2.01 Million
Q4 2020 Feb 25, 2021	SELL	$79.67 - $173.23 $15,535 - $33,779	-195 Reduced 1.21%	15,962 $2.44 Million
Q3 2020 Nov 30, 2020	SELL	$78.5 - $100.64 $32,185 - $41,262	-410 Reduced 2.47%	16,157 $1.96 Million
Q2 2020 Aug 17, 2020	SELL	$38.5 - $76.05 $7,892 - $15,590	-205 Reduced 1.22%	16,567 $1.22 Million
Q1 2020 May 08, 2020	BUY	$33.68 - $62.53 $563,196 - $1.05 Million	16,722 Added 33444.0%	16,772 $825,000
Q1 2019 May 17, 2019	BUY	$28.02 - $40.87 $1,401 - $2,043	50 New	50 $2,000

Others Institutions Holding CRSP

# of Institutions

489

Shares Held

57.9M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account

Front Row Advisors LLC Crispr Therapeutics Ag Transaction History